Steroid Hormone Action
Our research aims to determine and characterise the genes that mediate the actions of the sex steroid hormones oestrogen, progesterone, and androgens in steroid-responsive cancers, which constitute a third of all newly diagnosed cancers. In collaboration with the Cell Cycle and Apoptosis Groups, we have identified and are characterising a number of steroid regulated genes involved in the control of cell proliferation and death in breast cancer. In partnership with the Breast and Prostate Cancer Groups, we have demonstrated that some of these genes are new markers of cancer progression and response to therapy.
Staff
 Research OfficerDr Andrew Stone |
 Senior Research Assistant
Gillian Lehrbach |
 Research AssistantRachael McCloy |
News
$3.7 million to push cancer discoveries down the ‘pipeline’
14 Oct 2010
The Cancer Institute NSW has awarded the Garvan Institute’s Cancer Research Program $3.7 million, research funding that should lead to improved clinical decision-making for breast, prostate and pancreatic cancer within the next 5 years.
Professor Rob Sutherland awarded Order of Australia
14 Jun 2010
Professor Rob Sutherland, Director of Garvan’s Cancer Research Program, has been awarded an Officer of the Order of Australia (AO) for “distinguished service to medicine as an international contributor to the research of cancer, the development of Australia's research capacity and through leadership roles in advisory bodies.”
Top cancer research prize in NSW goes to Professor Rob Sutherland
MEDIA RELEASE:
24 May 2010
Professor Rob Sutherland, Director of the Cancer Research Program at Sydney’s Garvan Institute of Medical Research, has been awarded this year’s prestigious Cancer Institute NSW Premier's Award for Outstanding Cancer Researcher.
